Selenium in the treatment of mild-to-moderate Graves’ orbitopathy: a 5-year prospective controlled cohort study

Purpose Graves’ orbitopathy (GO) is the main extrathyroidal manifestation of Graves’ disease. However, limited studies have investigated the actual efficacy of selenium in GO therapy. This longitudinal study explored the effect of selenium on QOL and prognosis of patients with mild-to-moderate GO. M...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Endocrine 2024-06, Vol.84 (3), p.1072-1080
Hauptverfasser:	Wang, Chuyuan, Qiao, Jing, Liu, Shanshan, Piao, Sichen, Zhou, Yun, Hu, Yuedong, Wan, Chao, Sun, Yizhou, Ning, Hong, Chen, Lei, Zhang, He, Hu, Ruolin, Wang, Haoyu, Wang, Weiwei, Zhao, Lei, Mao, Jinyuan, Li, Min, Teng, Weiping, Shan, Zhongyan, Li, Yushu
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Clinical trials Diabetes Endocrinology Female Follow-Up Studies Graves Ophthalmopathy - drug therapy Graves' disease Humanities and Social Sciences Humans Internal Medicine Longitudinal Studies Male Medicine Medicine & Public Health Middle Aged multidisciplinary Original Article Patients Placebos Prospective Studies Quality of Life Science Selenium Selenium - therapeutic use Severity of Illness Index Treatment Outcome Vision
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!